>
Switch to:

Merck Gross Profit

: $32,760 Mil (TTM As of Jun. 2021)
View and export this data going back to 1949. Start your Free Trial

Merck's gross profit for the three months ended in Jun. 2021 was $8,298 Mil. Merck's gross profit for the trailing twelve months (TTM) ended in Jun. 2021 was $32,760 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Merck's gross profit for the three months ended in Jun. 2021 was $8,298 Mil. Merck's Revenue for the three months ended in Jun. 2021 was $11,402 Mil. Therefore, Merck's Gross Margin % for the quarter that ended in Jun. 2021 was 72.78%.

Merck had a gross margin of 72.78% for the quarter that ended in Jun. 2021 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Merck was 69.87%. The lowest was 60.30%. And the median was 65.05%.


Merck Gross Profit Historical Data

The historical data trend for Merck's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Gross Profit
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25,777.00 27,210.00 28,785.00 32,728.00 32,509.00

Merck Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Gross Profit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,606.00 9,070.00 6,982.00 8,410.00 8,298.00

Competitive Comparison

For the Drug Manufacturers - General subindustry, Merck's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Merck Gross Profit Distribution

For the Drug Manufacturers industry and Healthcare sector, Merck's Gross Profit distribution charts can be found below:

* The bar in red indicates where Merck's Gross Profit falls into.



Merck Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Merck's Gross Profit for the fiscal year that ended in Dec. 2020 is calculated as

Gross Profit (A: Dec. 2020 )=Revenue - Cost of Goods Sold
=47994 - 15485
=32,509

Merck's Gross Profit for the quarter that ended in Jun. 2021 is calculated as

Gross Profit (Q: Jun. 2021 )=Revenue - Cost of Goods Sold
=11402 - 3104
=8,298

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $32,760 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Merck's Gross Margin % for the quarter that ended in Jun. 2021 is calculated as

Gross Margin % (Q: Jun. 2021 )=Gross Profit (Q: Jun. 2021 ) / Revenue (Q: Jun. 2021 )
=(Revenue - Cost of Goods Sold) / Revenue
=8,298 / 11402
=72.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Merck  (NYSE:MRK) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Merck had a gross margin of 72.78% for the quarter that ended in Jun. 2021 => Durable competitive advantage


Merck Gross Profit Related Terms

Thank you for viewing the detailed overview of Merck's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck Business Description

Merck logo
Industry
Healthcare » Drug Manufacturers NAICS : 325412 SIC : 2834
Address
2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
Executives
Davis Robert M officer: EVP, Global Svcs & CFO 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Seidman Christine E director MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Coe Mary Ellen director 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Wendell Peter C director 1400 FASHION ISLAND BLVD. SUITE 1010 SAN MATEO CA 94404
Chattopadhyay Sanat officer: Exe V-P & Pres. MMD 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Clyburn Frank officer: EVP, Chief Commercial Officer 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Williams David Michael officer: EVP,Chief Info&Digital Officer MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Gerberding Julie L. officer: EVP Strat Comm, GI Pub Policy 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Craig Pamela J. director C/O ACCENTURE 161 N CLARK STREET CHICAGO IL 60601
Brun Leslie A director 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087
Glocer Thomas H director 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Russo Patricia F director SCHERING PLOUGH CORP ONE GIRALDA FARMS MADISON NJ 07940-1000
Lavizzo-mourey Risa J director GENERAL ELECTRIC COMPANY 5 NECCO STREET BOSTON MA 02210
Thulin Inge G director 1250 5TH AVENUE SOUTH NAPLES FL 34102
Cech Thomas R director 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033

Merck Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)